Abiopharma

🔍 Grade Joel T. (Executive)

Company: BAXTER INTERNATIONAL INC (BAX)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Acquired 102,712 shares of Common Stock, $1 par value (Direct)
  Date: 2025-09-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 222,560.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The reporting person received a grant of restricted stock units (RSUs) that are scheduled to vest on September 5, 2028, the first business day following the third anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan (the Plan). The RSUs will immediately vest if the reporting person's employment is terminated without Cause (as defined in the Plan).
• F2: Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.